CLINICAL_TRIALS
ClinicalTrials.gov record update
Sodium Stibogluconate in the Myelodysplastic Syndromes/Acute Myeloid Leukemia With One of the 65 Defined p53 Mutations That Can be Functionally Rescued by Sodium Stibogluconate
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT04906031
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:38:08.925740+00:00
- Published At
- 2021-06-09T00:00:00+00:00
- Record Updated At
- 2021-06-09
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Myelodysplastic Syndromes", "Acute Myeloid Leukemia", "Myeloid Malignancy", "Temperature-Sensitive p53 Mutation", "Sodium Stibogluconate", "P53 Mutation"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-06-09"- protocolSection.identificationModule.nctId
"NCT04906031"- protocolSection.identificationModule.officialTitle
"Sodium Stibogluconate in the Myelodysplastic Syndromes/Acute Myeloid Leukemia With One of the 65 Defined p53 Mutations That Can be Functionally Rescued by Sodium Stibogluconate"- protocolSection.statusModule.overallStatus
"UNKNOWN"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.